Home / 2024 (Page 82)

~ Cureskin witnesses surge in demand from Tier 2 and Tier 3 Cities across India~ Cureskin, a leading AI-powered dermatology platform delivering dermatology solutions to consumers nationwide via its innovative app & products, recently reached over 1.5 Crore cases. Notably, 90% of these users come from Tier

READ MORE

The two-day Clinical Rheumatology Conference 2024 (CRC2024) held at KIMS Hospitals, Secunderabad, concluded on Sunday with resounding success and overwhelming participation from more than 400 rheumatologists across the country. The biannual event, renowned for its focus on advancing treatment methodologies for rheumatic and musculoskeletal diseases,

READ MORE

Overcoming the Challenges, a Surgical Triumph in Managing Complex 10-year-old Incisional Hernia and Comorbid Conditions at Bangalore   A hernia is a medical condition where a portion of an organ, typically the intestine, is displaced and protrudes through a weakened area in the abdominal wall. This protrusion

READ MORE

Dr. Ravi GAUR. Founder & Director DRG Path Lab,New Delhi Chairman Medical Advisory Committee Unipath Specialty Laboratory, Ahmadabad In the ever-evolving landscape of healthcare, diagnostics plays a pivotal role in guiding clinical decisionmaking, personalized treatment plans, and overall patient care. Emerging trends are revolutionizing the

READ MORE

Heman Vasavada, President, Trivitron Healthcare The Evolution of Diagnostics: From Reactive to Predictive Healthcare Traditionally the diagnostics industry operated on a reactive basis, where diseases were diagnosed after symptoms had become apparent. This approach while effective for many conditions often led to delayed interventions with treatments being

READ MORE

BHUPENDRA CHAUDHARY PRESIDENT – SALES & MARKETING TRANSASIA BIO-MEDICALS LTD. In the realm of modern medicine, haematology analyzers play a pivotal role in diagnosing and monitoring various blood disorders. Among the multitude of parameters these analyzers measure, the reticulocyte parameter stands out as a crucial indicator of bone marrow

READ MORE

VEENA KOHLI FOUNDER & CEO, VANGUARD DIAGNOSTICS (P) LIMITED & MANAGING DIRECTOR, DIAGON - VANGUARD DIAGNOSTICS INDIA • The Indian in-vitro diagnostics (IVD) market, • valued at US$ 1.3 billion in 2023, is on a trajectory • of significant growth, projected to reach US$ 2.3 • billion by 2027 with a CAGR of approximately 15%. • This

READ MORE